Minkyeong Kim

Academic Qualifications

• Mar. 2005 – Feb. 2009 Pharmacy, Pusan National University, Pusan, Republic of Korea

B.S.(Pharmacy)

• Mar. 2009 – Feb. 2013 School of Medicine, Pusan National University, Pusan, Republic of Korea

M.S. (Neurology)

• Mar. 2016 – Feb. 2018 School of Medicine, Pusan National University, Pusan, Republic of Korea

Ph.D. (Neurology)

Medical License

• Feb. 2013 M.D., granted by Ministry of Health and Welfare, Republic of Korea (113364)

• Mar. 2018 Board of Neurology, granted by Ministry of Health and Welfare, Republic of Korea (2059)

Training and Work Experience

• Mar. 2013 – Feb. 2014 Internship, Pusan National University Yangsan Hospital, Republic of Korea

• Mar. 2014 – Feb. 2018 Residency, Department of Neurology, Pusan National University Yangsan Hospital, Republic of Korea

• Mar. 2018 – Feb. 2020 Fellowship, Division of Movement Disorders, Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Honors

• 2018 Won-Young Lee Brain Research Scholarship Awards

• 2019 Award for Outstanding Poster Presentation in Korea Movement Disorders Society Conference

• 2019 Travel grant, International Congress of Parkinson’s Disease and Movement Disorders, Nice, 2019

Research Experiences

• 2018 Co-researcher, Whole Exome Sequencing in Patients with Undiagnosed Ataxia

• 2019 – 2020 Co-researcher, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase Ⅳ Clinical Trial to Evaluate and Compare the Safety and Efficacy of C-Trelin OD Tab. 5mg (Taltirelin Hydrate) in Patients with Ataxia Induced by Spinocerebellar Degeneration.

• 2020~ Participating researcher, Development of clinical sample protocol for Parkinson’s syndrome patients; Parkinson's disease biomarker search and treatment technology clinical effectiveness verification

Relevant Publications

As a main author

• 1. Kim M, Yoo S, Kim D, et al. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease. Neurol Sci 2021.

• 2. Kim M, Ahn JH, Mun JK, et al. Extracerebellar Signs and Symptoms in 117 Korean Patients with Early-Stage Spinocerebellar Ataxia. J Clin Neurol 2021;17:242-248.

• 3. Kim M, Kim AR, Park J, et al. Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation. Clinical Neurology and Neurosurgery 2020;199:106267.

• 4. Kim M, Kim AR, Kim JS, et al. Clarification of undiagnosed ataxia using whole-exome sequencing with clinical implications. Parkinsonism Relat Disord 2020;80:58-64.

• 5. Kim M, Oh SH, Cho JW, Lee J-H. Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Syndrome in a Korean Family. JMD 2020;13:244-246.

• 6. Kim M, Ahn JH, Cho Y, Kim JS, Youn J, Cho JW. Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias. Scientific Reports 2019;9:17329.

• 7. Kim M, Cho KR, Park J-H, et al. Bilateral subthalamic deep brain stimulation is an effective and safe treatment option for the older patients with Parkinson’s disease. Clinical Neurology and Neurosurgery 2018;173:182-186.

• 8. Kim M, Lee H, Cho HJ, et al. Pathologic Correlation of Paramagnetic White Matter Lesions in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia. J Neuropathol Exp Neurol 2017;76:924-928.

• 9. Kim MK, Yuk JW, Kim HS, Park KJ, Kim DS. Autonomic dysfunction in SCN9A-associated primary erythromelalgia. Clin Auton Res 2013;23:105-107

As a co-author

• 1. Lee YH, Ando T, Lee JJ, et al. Later-Onset Multiple System Atrophy: A Multicenter Asian Study. Movement Disorders 2020;35:1692-1693.

• 2. Ahn JH, Kim M, Park S, et al. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial. Parkinsonism Relat Disord 2020;75:50-54.

• 3. Mun JK, Kim AR, Ahn JH, et al. Successful Pallidal Stimulation in a Patient with KMT2B-Related Dystonia. JMD 2020;13:154-158.

• 4. Ahn JH, Kim M, Mun JK, et al. The Dysfunctional Autonomic Function and "Dysfunctional" Fatigue in Drug Naïve Parkinson's Disease. J Parkinsons Dis 2020;10:605-612.

• 5. Jo H, Kim M, Park S, et al. Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T). J Alzheimers Dis 2019;71:7-13.

• 6. Ha J, Na BS, Ahn JH, et al. Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine. Tremor Other Hyperkinet Mov (N Y) 2019;9.

• 7. Ahn JH, Kim M, Kim JS, et al. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome. Parkinsonism Relat Disord 2019;66:80-86.

• 8. Ahn JH, Kim AR, Lee C, et al. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review. Cerebellum 2019;18:659-664.

• 9. Na BS, Ha J, Park JH, et al. Comparison of gait parameters between drug-naive patients diagnosed with multiple system atrophy with predominant parkinsonism and Parkinson's disease. Parkinsonism Relat Disord 2019;60:87-91.

• 10. Park MG, Kim MK, Chae SH, Kim HK, Han J, Park KP. Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke. Neurol Sci 2018;39:243-249.

Poster Presentations

• 1. Whole exome sequencing in patients with undiagnosed ataxia in a Korean population. 2020 International Congress of Parkinson’s Disease and Movement Disorders

• 2. Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Syndrome in a Korean Family. 2020 Congress of Neurology, Korea

• 3. Differential Value of Brain Magnetic Resonance Imaging in MSA-C and SCAs. International Congress of Parkinson’s Disease and Movement Disorders, Nice, 2019

• 4. Asymmetric dopaminergic depletion is related with cardiovascular non-motor symptom in drug naïve Parkinson’s disease patients. World Parkinson Congress, Kyoto, Japan, 2019

• 5. Frequencies, genetic, clinical and radiologic characterization of spinocerebellar ataxia in Korea. XXIV International Association of Parkinsonism and Related Disorders (IAPRD), Lyon, France, 2018

• 6. The clinical, radiologic and pathologic characteristics of Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigemented glia: ten cases including new genetically confirmed cases. The 4th International Conference on Molecular Neurodegeneration (ICMN), 2016

• 7. Pathologically, and genetically diagnosed Familial Amyloid Polyneuropathy. The 21th International Congress of the World Muscle Society, Granada, Spain, 2016